X-48700221-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003173.4(SUV39H1):c.296G>A(p.Arg99Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000191 in 1,203,515 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 9 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.000018 ( 0 hom. 9 hem. )
Consequence
SUV39H1
NM_003173.4 missense
NM_003173.4 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 6.54
Genes affected
SUV39H1 (HGNC:11479): (SUV39H1 histone lysine methyltransferase) This gene encodes an evolutionarily-conserved protein containing an N-terminal chromodomain and a C-terminal SET domain. The encoded protein is a histone methyltransferase that trimethylates lysine 9 of histone H3, which results in transcriptional gene silencing. Loss of function of this gene disrupts heterochromatin formation and may cause chromosome instability. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10486305).
BS2
High Hemizygotes in GnomAdExome4 at 9 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SUV39H1 | NM_003173.4 | c.296G>A | p.Arg99Gln | missense_variant | 3/6 | ENST00000376687.4 | NP_003164.1 | |
SUV39H1 | NM_001282166.2 | c.329G>A | p.Arg110Gln | missense_variant | 3/6 | NP_001269095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SUV39H1 | ENST00000376687.4 | c.296G>A | p.Arg99Gln | missense_variant | 3/6 | 1 | NM_003173.4 | ENSP00000365877.4 | ||
SUV39H1 | ENST00000337852.10 | c.329G>A | p.Arg110Gln | missense_variant | 3/6 | 2 | ENSP00000337976.6 | |||
ENSG00000232828 | ENST00000416061.1 | n.610C>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111495Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33705
GnomAD3 genomes
AF:
AC:
3
AN:
111495
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33705
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000182 AC: 3AN: 164970Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 53368
GnomAD3 exomes
AF:
AC:
3
AN:
164970
Hom.:
AF XY:
AC XY:
0
AN XY:
53368
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000183 AC: 20AN: 1091968Hom.: 0 Cov.: 34 AF XY: 0.0000251 AC XY: 9AN XY: 358484
GnomAD4 exome
AF:
AC:
20
AN:
1091968
Hom.:
Cov.:
34
AF XY:
AC XY:
9
AN XY:
358484
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111547Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33767
GnomAD4 genome
AF:
AC:
3
AN:
111547
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33767
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 06, 2021 | The c.296G>A (p.R99Q) alteration is located in exon 3 (coding exon 3) of the SUV39H1 gene. This alteration results from a G to A substitution at nucleotide position 296, causing the arginine (R) at amino acid position 99 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
.;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
0.22
.;B
Vest4
MutPred
0.33
.;Loss of catalytic residue at R99 (P = 0.02);
MVP
MPC
1.4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at